Prevalence of Acute Reactions to Iopromide: Postmarketing Surveillance Study of 74,717 Patients

References

• Bettmann MA. Frequently asked questions: iodinated contrast agents. Radiographics 2004; 24 Suppl 1: S3–10
   PubMed Web of Science ®Google Scholar
• Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006; 12: 210–5
   PubMedGoogle Scholar
• Vogl TJ, Honold E, Wolf M, Mohajeri H, Hammerstingl R. Safety of iobitridol in the general population and at-risk patients. Eur Radiol 2006; 16: 1288–97
   PubMed Web of Science ®Google Scholar
• Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621–8
   PubMed Web of Science ®Google Scholar
• Mortele KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. Am J Roentgenol 2005; 184: 31–4
   PubMed Web of Science ®Google Scholar
• Palmer FJ. The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol 1988; 32: 426–8
   PubMedGoogle Scholar
• Petersein J, Peters CR, Wolf M, Hamm B. Results of the safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol 2003; 13: 2006–11
   PubMed Web of Science ®Google Scholar
• Schrott KM, Behrends B, Clauss W, Kaufmann J, Lehnert J. Iohexol in excretory urography. Results of drug monitoring. Fortschr Med 1986; 104: 153–6
   PubMedGoogle Scholar
• Munechika H, Hiramatsu Y, Kudo S, Sugimura K, Hamada C, Yamaguchi K, et al. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 2003; 13: 185–94
   PubMed Web of Science ®Google Scholar
• Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. Am J Roentgenol 1991; 156: 825–32
   PubMed Web of Science ®Google Scholar
• Bush WH, Swanson DP. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. Am J Roentgenol 1991; 157: 1153–61
   PubMed Web of Science ®Google Scholar
• Lasser EC, Berry CC, Talner LB, Santini LC, Lang EK, Gerber FH, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987; 317: 845–9
   PubMed Web of Science ®Google Scholar
• Shehadi WH. Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology 1982; 143: 11–7
   PubMed Web of Science ®Google Scholar
• Bettmann MA, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology 1997; 203: 611–20
   PubMed Web of Science ®Google Scholar
• Dahlstrom K, Shaw DD, Clauss W, Andrew E, Sveen K. Summary of U.S. and European intravascular experience with iohexol based on the clinical trial program. Invest Radiol 1985; 20 Suppl 1: S117–21
   Web of Science ®Google Scholar
• Miles SG, Rasmussen JF, Litwiller T, Osik A. Safe use of an intravenous power injector for CT: experience and protocol. Radiology 1990; 176: 69–70
   PubMed Web of Science ®Google Scholar
• Jacobs JE, Birnbaum BA, Langlotz CP. Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 1998; 209: 411–6
   PubMed Web of Science ®Google Scholar
• Lasser EC. Contrast reactions. Eked data from contrast-reaction surveys. Invest Radiol 1990; 25 Suppl 1: S14–5
   PubMed Web of Science ®Google Scholar
• Narita S, Goldblum RM, Watson CS, Brooks EG, Estes DM, Curran EM, et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect 2007; 115: 48–52
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Webb JA. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 2001; 11: 1720–8
   PubMed Web of Science ®Google Scholar
• Delaney A, Carter A, Fisher M. The prevention of anaphylactoid reactions to iodinated radiological contrast media: a systematic review. BMC Med Imaging 2006; 6: 2
   PubMedGoogle Scholar
• American College of Radiology American College of Radiology manual on contrast media. 5th ed. Reston, Va: American College of Radiology; 2004.
   Google Scholar
• Michel A, Abudulah A, Schumann W. Spontaneous reporting of adverse drug reactions: estimation of under-reporting for contrast media reactions in 14 countries. Pharmacoepidemiol Drug Saf 2001; 10(S1)S34
   Google Scholar
• Joelson S, Joelson IB, Wallander MA. Geographical variation in adverse event reporting rates in clinical trials. Pharmacoepidemiol Drug Saf 1997; 6 Suppl 3: S31–5
   PubMed Web of Science ®Google Scholar